Best pulmonologists: TOP 310 doctors

• Expert in Pulmonology, specializing in asthma, COPD, and lung cancer treatments.
• International training in Turkey, with a focus on chest diseases and thoracic surgery.
• Specializes in using Endobronchial Ultrasonography (EBUS) for pulmonary diagnostics.
• Renowned for interventional bronchoscopy and endobronchial treatments.
• Trained in managing respiratory infections and diffuse parenchymal lung diseases.
• Experienced in vascular diseases of the lung and pulmonary embolism management.
• Completed specialization training at Yedikule Chest Diseases and Thoracic Surgery Center.
• Served as a Training Supervisor at Süreyyapaşa Chest Diseases and Thoracic Surgery Hospital.
• Conducted remote consultations for patients with complex pulmonological conditions.

Prof. Michele Ciccarelli is the Pneumology Unit Director in Humanitas Research Hospital.

He has acquired significant experience in managing infectious pneumonias, treating about 300 cases annually. 

He has also acquired a wide experience in managing respiratory allergies of bronchial asthma and COPD with over 500 patients followed in these pathologies.

Previous experience:

1988-1995 Hospital of Niguarda, Milan, Italy
Visiting doctor at the Centre for High Specialisation in Allergology and Clinical Immunology with full-time specialisation in the Department of Pneumology Piazza.

Other medical areas of interest:

• Obstructive pathology of the airways
• Pulmonary infectivity
• Bronchoscopy techniques
• Pulmonary oncology
• Interstitial pneumopathies
• Non-invasive ventilator therapy
• Sleep medicine
• Pneumopathies in the course of systemic diseases

Research areas of interest:

• Lung oncology
• Community and hospital acquired pneumonia
• Bronchial asthma
• Chronic obstructive pulmonary disease

Teaching experience: Medicine and Surgery Professor at “Università degli Studi” of Milan.

Scientific activities: Medicine and Surgery Professor at “Associazione Italiana Pneumologi Ospedalieri” (AIPO).

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21

During his career, Dr. Covaro has a continuous participation in international meetings and contributed to several articles published in scientific magazines. Dr. Covaro is a member of several professional organizations, including the Spanish Society of Orthopedics, AOspine, GEER and Eurospine.

Currently, Dr. Covaro attends his patients at the Institut Universitari Dexeus and the Hospital Universitari de Bellvitge, in Barcelona. To make an appointment with Dr. Augusto Covaro, contact ICATME, Institut Universitari Dexeus